Umbilical Cord Mesenchymal Stem Cells Ameliorate Premature Ovarian Insufficiency in Rats.
Meiliang ZhangTingting XieWeiyou DaiBo ZhaoYaqin ZhengJianmiao HuRuolang PanLiang WangPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
Premature ovarian insufficiency (POI) or premature ovarian failure (POF) is known as a state of hypergonadotropic hypogonadism. Stem cell therapy is expected to be used in the treatment of POI. The aim of the present study was to explore the feasibility and effectiveness of umbilical cord mesenchymal stem cell (UCMSC) transplantation for the treatment of POI in a rat model of POI induced by cyclophosphamide (CTX) injection. The ovarian function was examined by evaluating the weight of the ovary and body, estrus cycle, ovarian morphology, hormonal secretion, granulosa cell apoptosis, and fertility. The results showed that the ovarian function indicators of the modeled rats were comparable to those of the control rats after UCMSC transplantation, indicating that the ovarian function of the modeled rats recovered to a satisfactory extent. Our research may provide an experimental clue for the clinical application of UCMSC transplantation in the treatment of POI. Further experiments will focus on the detailed signaling pathway study of the molecular mechanisms of injury and repairment on the treatment with UCMSCs transplantation in the rat POI models.
Keyphrases
- mesenchymal stem cells
- umbilical cord
- cell therapy
- bone marrow
- systematic review
- stem cells
- physical activity
- type diabetes
- low dose
- insulin resistance
- epithelial mesenchymal transition
- replacement therapy
- cell proliferation
- escherichia coli
- multidrug resistant
- polycystic ovary syndrome
- adipose tissue
- weight loss
- ultrasound guided